Not Yet Recruiting
A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder Cancer
NCT07279597
- Conditions
- Muscle-invasive Bladder Urothelial Carcinoma
- Locations
-
Not specified